作者：
Darpo,B. [1]
;
Sarapa,N. [2]
;
Garnett,C. [3]
;
Benson,C. [4]
;
Dota,C. [5]
;
Ferber,G. [6]
;
Jarugula,V. [7]
;
Johannesen,L. [8]
;
Keirns,J. [9]
;
Krudys,K. [10]
;
Ortemann-Renon,C. [11]
;
Riley,S. [12]
;
Rogers-Subramaniam,D. ;
Stockbridge,N.
作者单位：
Drug Metabolism and Pharmacokinetics, Novartis Institute for Biomedical Research, East Hanover, NJ
[1]
Global Clinical Pharmacology and Exploratory Development, Astellas Pharma Global Development, Inc.,
[2]
Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, US Food and
[3]
Clinical Science, Bayer Healthcare, Inc., Whippany, NJ, United States
[4]
Certara, St. Louis, MO, United States
[5]
AstraZeneca R and D M?lndal, M?lndal, Sweden
[6]
Clinical and Exploratory Pharmacology, Sanofi, Bridgewater, NJ, United States
[7]
Clinical Pharmacology, Specialty Care Business Unit, Pfizer Inc., Groton, CT, United States
[8]
Lilly Corporate Center, Eli Lilly and Co., Indianapolis, IN, United States
[9]
Department of Clinical Sciences, Karolinska Institutet, Danderyd's Hospital, Stockholm, Sweden
[10]
Statistik Georg Ferber GmbH, CH-4125, Riehen, Switzerland
[11]
Division of Pharmacometrics, Center of Drug Evaluation and Research, US Food and Drug
[12]
发布时间
2014-04-30
换一批
